{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:57:52Z","timestamp":1773925072925,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.3816\/ccc.2005.n.040","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:06:20Z","timestamp":1221080780000},"page":"279-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Outcomes in Elderly Patients with Advanced Colorectal Cancer Treated with Capecitabine: A Population-Based Analysis"],"prefix":"10.3816","volume":"5","author":[{"given":"Cheryl","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharlene","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2005.n.040_bib1","author":"Canadian Cancer Society"},{"key":"10.3816\/CCC.2005.n.040_bib2","author":"American Cancer Society"},{"key":"10.3816\/CCC.2005.n.040_bib3","author":"National Cancer Institute"},{"key":"10.3816\/CCC.2005.n.040_bib4","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2004.03.104","article-title":"Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis","volume":"22","author":"Thirion","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2005.n.040_bib6","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.3816\/CCC.2005.n.040_bib8","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO.2003.11.126","article-title":"Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial","volume":"21","author":"Rothenberg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200464010-00003","article-title":"First-line treatment strategies to improve survival in patients with advanced colorectal cancer","volume":"64","author":"Gill","year":"2004","journal-title":"Drugs"},{"key":"10.3816\/CCC.2005.n.040_bib10","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1200\/JCO.2001.19.21.4097","article-title":"Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study","volume":"19","author":"Van Cutsem","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib11","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2001.19.8.2282","article-title":"Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study","volume":"19","author":"Hoff","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"issue":"7 suppl","key":"10.3816\/CCC.2005.n.040_bib13","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-#","article-title":"Representation of older patients in cancer treatment trials","volume":"74","author":"Trimble","year":"1994","journal-title":"Cancer"},{"key":"10.3816\/CCC.2005.n.040_bib14","first-page":"213","article-title":"Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study","volume":"7","author":"Sundararajan","year":"2001","journal-title":"Cancer J"},{"key":"10.3816\/CCC.2005.n.040_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/93.11.850","article-title":"Age and adjuvant chemotherapy use after surgery for stage III colon cancer","volume":"93","author":"Schrag","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CCC.2005.n.040_bib16","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W","article-title":"Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study","volume":"82","author":"Yancik","year":"1998","journal-title":"Cancer"},{"key":"10.3816\/CCC.2005.n.040_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/annonc\/mdh344","article-title":"Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials","volume":"15","author":"Folprecht","year":"2004","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa010957","article-title":"A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients","volume":"345","author":"Sargent","year":"2001","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2005.n.040_bib19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1200\/JCO.1999.17.8.2412","article-title":"Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older","volume":"17","author":"Popescu","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib20","first-page":"325","article-title":"5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study","volume":"4","author":"D'Andre","year":"2005","journal-title":"Clin Colorectal Cancer"},{"key":"10.3816\/CCC.2005.n.040_bib21","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1200\/JCO.1998.16.11.3537","article-title":"Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer","volume":"16","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2005.n.040_bib22","unstructured":"Jonker DJ, Vincent M, Kerr I, et al. Dose reduced first-line capecitabine monotherapy in older and less fit patients with advanced colorectal cancer. In: Proceedings of 2004 Gastrointestinal Cancers Symposium; January 22-24, 2004; San Francisco, CA. Abstract #212."},{"key":"10.3816\/CCC.2005.n.040_bib23","first-page":"262","article-title":"A phase II study of capecitabine in elderly patients as 1st line treatment for patients with advanced or metastatic colorectal cancer","volume":"23","author":"Feliu","year":"2004","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811701967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811701967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:58:45Z","timestamp":1761519525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811701967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1533002811701967"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2005.n.040","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in Elderly Patients with Advanced Colorectal Cancer Treated with Capecitabine: A Population-Based Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2005.n.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}